Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2013 08:34 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulatory Approval in China and 33% Increase in Dividend to 20 Cents

DUBLIN, Ireland, April 25, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
April 16, 2013 05:50 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce First Quarter Fiscal Year 2013 Financial Results

DUBLIN, Ireland, April 16, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
March 05, 2013 07:17 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Results for Fiscal Year 2012

DUBLIN, Ireland, March 5, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point of care and clinical laboratory markets,...
February 20, 2013 11:00 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2012 Financial Results

DUBLIN, Ireland, Feb. 20, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
October 18, 2012 08:02 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 3 Financial Results

Profit After Tax increases by 13% to $4.5m EPS increases by 12% to 20.7 cents per ADR DUBLIN, Ireland, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer...
October 04, 2012 05:29 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2012 Financial Results

DUBLIN, Ireland, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
July 12, 2012 07:59 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 2 Financial Results EPS of 20 Cents Per ADR -- an Increase of 11%

DUBLIN, Ireland, July 12, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
July 05, 2012 07:07 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2012 Financial Results

DUBLIN, Ireland, July 5, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
June 26, 2012 12:02 ET | Source: Trinity Biotech plc

Trinity Biotech Added to Membership of Russell Global Index

DUBLIN, Ireland, June 26, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
June 06, 2012 07:00 ET | Source: Trinity Biotech plc

Trinity Biotech plc Announces Details of Its Dividend and Share Buyback Program

DUBLIN, Ireland, June 6, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...